From Surf Wiki (app.surf) — the open knowledge base
2C-T-35
| Column 1 |
|---|
| 2C-T-DFM; 4-Difluoromethylthio-2,5-dimethoxyphenethylamine |
| IUPAC name |
| 2-[4-(difluoromethylsulfanyl)-2,5-dimethoxyphenyl]ethanamine |
| .mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}169149411 |
| C11H15F2NO2S |
| 263.30 g·mol−1 |
| Interactive image |
| SMILES |
| COC1=CC(=C(C=C1CCN)OC)SC(F)F |
| InChI |
| InChI=1S/C11H15F2NO2S/c1-15-8-6-10(17-11(12)13)9(16-2)5-7(8)3-4-14/h5-6,11H,3-4,14H2,1-2H3Key:IMXLEUNJGUBEMC-UHFFFAOYSA-N |
2C-T-35, also known as 2C-T-DFM or as 4-difluoromethylthio-2,5-dimethoxyphenethylamine, is a designer drug from the substituted phenethylamine family, which was first synthesised by Josh Hartsel and colleagues in 2024. It is a potent agonist at the serotonin receptor 5-HT2A in vitro, with a binding affinity (Ki) of 6.3 nM. In animal studies, 2C-T-DFM was the most effective compound at producing a head-twitch response out of a series of related analogues, with an average of 33 head-twitches per 10 minutes compared to 21 for 2C-T-TFM. While it had previously been proposed as a theoretical compound, 2C-T-35 is not known to have been tested in humans. It is a controlled substance in Canada under phenethylamine blanket-ban language.
- 2C (psychedelics)
- 2C-T-21.5
- 2C-T-29
Ask Mako anything about 2C-T-35 — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report